Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Vivitrol and OLANI
NCT04716881Phase 1Completed
- Sponsor
- Go Medical Industries
- Start
- Jan 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of naltrexone in opioid use disorder (OUD), sponsored by Go Medical Industries. Primary endpoints: Median Cmax of Naltrexone, Median Tmax of Naltrexone and 6 more. Started Jan 2021; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04716881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04716881.